Karin Yamada

574 total citations
15 papers, 76 citations indexed

About

Karin Yamada is a scholar working on Oncology, Epidemiology and Obstetrics and Gynecology. According to data from OpenAlex, Karin Yamada has authored 15 papers receiving a total of 76 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Epidemiology and 6 papers in Obstetrics and Gynecology. Recurrent topics in Karin Yamada's work include Endometrial and Cervical Cancer Treatments (6 papers), Cervical Cancer and HPV Research (5 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Karin Yamada is often cited by papers focused on Endometrial and Cervical Cancer Treatments (6 papers), Cervical Cancer and HPV Research (5 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Karin Yamada collaborates with scholars based in United States, Japan and Italy. Karin Yamada's co-authors include Masahiko Hirata, Clarisse Zaitz, Fred Saad, Maha Hussain, Karim Fizazi, Christian Kappeler, Bertrand Tombal, Iris Kuss, Matthew R. Smith and Cora N. Sternberg and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Gynecologic Oncology.

In The Last Decade

Karin Yamada

13 papers receiving 75 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin Yamada United States 4 25 25 18 13 13 15 76
Petra Muckova Germany 4 5 0.2× 9 0.4× 21 1.2× 6 0.5× 10 0.8× 5 122
Dalia Larios United States 5 20 0.8× 10 0.4× 2 0.1× 5 0.4× 6 0.5× 9 115
Nathan Pate United States 5 12 0.5× 3 0.1× 2 0.1× 5 0.4× 19 1.5× 13 70
Bernard Lam Canada 4 6 0.2× 14 0.6× 2 0.1× 53 4.1× 37 2.8× 14 121
Hidetoshi Matsuoka Japan 4 14 0.6× 18 0.7× 11 0.8× 15 1.2× 9 88
Nicholas Machin United Kingdom 6 9 0.4× 7 0.3× 2 0.1× 6 0.5× 71 5.5× 14 157
Victoria Zaksas United States 5 16 0.6× 11 0.4× 19 1.5× 50 3.8× 6 109
Domenique D. Zomer-van Ommen Netherlands 5 87 3.5× 10 0.4× 2 0.1× 3 0.2× 15 1.2× 10 162
R Vives Spain 5 6 0.2× 36 1.4× 4 0.2× 2 0.2× 10 0.8× 10 73
Shirley Hodgson United Kingdom 4 4 0.2× 22 0.9× 4 0.2× 6 0.5× 2 0.2× 7 67

Countries citing papers authored by Karin Yamada

Since Specialization
Citations

This map shows the geographic impact of Karin Yamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Yamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Yamada more than expected).

Fields of papers citing papers by Karin Yamada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Yamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Yamada. The network helps show where Karin Yamada may publish in the future.

Co-authorship network of co-authors of Karin Yamada

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Yamada. A scholar is included among the top collaborators of Karin Yamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Yamada. Karin Yamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
3.
4.
Gokhale, Mugdha, et al.. (2024). Characteristics, treatment patterns, and outcomes in patients with high-risk locally advanced cervical cancer. Cancer Treatment and Research Communications. 39. 100800–100800. 3 indexed citations
5.
Duska, Linda, Yang Xiang, Kosei Hasegawa, et al.. (2024). Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: A randomized, double-blind, phase III ENGOT-cx11/GOG-3047/KEYNOTE-A18 study. Gynecologic Oncology. 190. S8–S9. 3 indexed citations
6.
7.
8.
Gokhale, Mugdha, et al.. (2023). Treatment patterns and outcomes among locally advanced cervical cancer patients receiving concurrent chemoradiotherapy.. Journal of Clinical Oncology. 41(16_suppl). e17511–e17511. 1 indexed citations
9.
Colombo, Nicoletta, Robert L. Coleman, Xiaohua Wu, et al.. (2022). ENGOT-ov65/KEYNOTE-B96: Phase 3, randomized, double-blind study of pembrolizumab versus placebo plus paclitaxel with optional bevacizumab for platinum-resistant recurrent ovarian cancer.. Journal of Clinical Oncology. 40(16_suppl). TPS5617–TPS5617. 5 indexed citations
10.
Smith, Matthew R., Fred Saad, Maha Hussain, et al.. (2018). ARASENS: A phase 3 trial of darolutamide in combination with docetaxel for men with metastatic hormone-sensitive prostate cancer (mHSPC).. Journal of Clinical Oncology. 36(6_suppl). TPS383–TPS383. 19 indexed citations
11.
Tombal, Bertrand, Fred Saad, Maha Hussain, et al.. (2017). ARASENS: A phase 3 trial of darolutamide in males with metastatic hormone-sensitive prostate cancer (mHSPC). Annals of Oncology. 28. v291–v292. 1 indexed citations
12.
13.
Hirata, Masahiko, et al.. (2016). Use of a maze test to assess spatial learning and memory in cattle: Can cattle traverse a complex maze?. Applied Animal Behaviour Science. 180. 18–25. 17 indexed citations
14.
Yamada, Karin, et al.. (2011). Cutaneous sporotrichosis treatment with potassium iodide: a 24 year experience in São Paulo state, Brazil. Revista do Instituto de Medicina Tropical de São Paulo. 53(2). 89–93. 18 indexed citations
15.
Taniguchi, H, Kazuhiro Fukuda, Makoto Yamamoto, et al.. (2000). [A case of effective chemotherapy using CAF followed by docetaxel for advanced breast cancer].. PubMed. 27(10). 1577–80. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Petra Muckova Breakdown of academic impact, for papers by Dalia Larios Breakdown of academic impact, for papers by Nathan Pate Breakdown of academic impact, for papers by Bernard Lam Breakdown of academic impact, for papers by Hidetoshi Matsuoka Breakdown of academic impact, for papers by Nicholas Machin Breakdown of academic impact, for papers by Victoria Zaksas Breakdown of academic impact, for papers by Domenique D. Zomer-van Ommen Breakdown of academic impact, for papers by R Vives Breakdown of academic impact, for papers by Shirley Hodgson
Rankless by CCL
2026